Chapter: 1 INTRODUCTION
1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PATENT ANALYSIS
3.3.1. Patent analysis, by year
3.3.2. Patent analysis, by country
3.4. TOP IMPACTING FACTORS
3.5. DRIVERS
3.5.1. Advantages of 3D culture techniques over 2D techniques
3.5.2. Augmented investments in R&D activities
3.5.3. Rise in prevalence rate of cancer
3.5.4. Increase in demand for organ transplantation
3.6. RESTRAINTS
3.6.1. Dearth of skilled professionals
3.6.2. Budget restriction for research-related activities
3.7. OPPORTUNITIES
3.7.1. Technological advancements
Chapter: 4 GLOBAL 3D CELL CULTURE MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SCAFFOLD-BASED PLATFORM
4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Macro-porous Scaffold-based Platform
4.2.5. Micro-porous Scaffold-based Platform
4.2.6. Nano-porous Scaffold-based Platform
4.2.7. Solid Scaffolds Platform
4.3. SCAFFOLD-FREE PLATFORM
4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.4. GELS
4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.5. BIOREACTORS
4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.6. MICROCHIPS
4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.7. SERVICES
4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
Chapter: 5 GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. CANCER RESEARCH
5.2.1. Market size and forecast
5.3. STEM CELL RESEARCH
5.3.1. Market size and forecast
5.4. DRUG DISCOVERY
5.4.1. Market size and forecast
5.5. REGENERATIVE MEDICINE
5.5.1. Market size and forecast
Chapter: 6 GLOBAL 3D CELL CULTURE MARKET, BY END USER
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
6.2.1. Market size and forecast
6.3. CONTRACT RESEARCH LABORATORIES
6.3.1. Market size and forecast
6.4. ACADEMIC INSTITUTES
6.4.1. Market size and forecast
Chapter: 7 3D CELL CULTURE MARKET, BY GEOGRAPHY
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. NORTH AMERICA
7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S.
7.2.5. Canada
7.2.6. Mexico
7.3. EUROPE
7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany
7.3.5. France
7.3.6. UK
7.3.7. Rest of Europe
7.4. ASIA-PACIFIC
7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. China
7.4.5. Japan
7.4.6. India
7.4.7. Australia
7.4.8. Rest of Asia-Pacific
7.5. LAMEA
7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil
7.5.5. Saudi Arabia
7.5.6. Republic of South Africa
7.5.7. Rest of LAMEA
Chapter: 8 COMPANY PROFILES
8.1. 3D BIOTEK LLC
8.1.1. Company overview
8.1.2. Key strategic moves and developments
8.2. ADVANCED BIOMATRIX, INC.
8.2.1. Company overview
8.3. BECTON, DICKINSON AND COMPANY
8.3.1. Company overview
8.3.2. Operating business segments
8.3.3. Business performance
8.4. CORNING INCORPORATED
8.4.1. Company overview
8.4.2. Operating business segments
8.4.3. Business performance
8.4.4. Key strategic moves and developments
8.5. KURARAY CO., LTD.
8.5.1. Company overview
8.5.2. Operating business segments
8.5.3. Business performance
8.6. LONZA GROUP LTD
8.6.1. Company overview
8.6.2. Operating business segments
8.6.3. Business performance
8.6.4. Key strategic moves and developments
8.7. MERCK & CO., INC.
8.7.1. Company overview
8.7.2. Operating business segments
8.7.3. Business performance
8.7.4. Key strategic moves and developments
8.8. SYNTHECON, INCORPORATED
8.8.1. Company overview
8.9. THERMO FISHER SCIENTIFIC INC.
8.9.1. Company overview
8.9.2. Operating business segments
8.9.3. Business performance
8.9.4. Key strategic moves and developments
8.10. VWR CORPORATION
8.10.1. Company overview
8.10.2. Business performance